跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58,489 条关于
“MonumenTAL-1”
全部
58,489
临床试验
34,709
药物
7,244
机构
1,383
资讯
15,153
去年
Talquetamab Treatment Shows Low Incidence of Neurological Adverse Events in Multiple Myeloma Patients
4年前
Bispecific Antibodies Teclistamab and Talquetamab Show Promise in Multiple Myeloma Treatment
2年前
Talquetamab Dose Reductions Maintain Efficacy While Reducing Toxicities in Relapsed/Refractory Multiple Myeloma
去年
GPRC5D-Targeted Therapy Shows Promise in Multiple Myeloma Treatment
去年
Talquetamab Step-Up Dosing Strategies Mitigate Cytokine Release Syndrome in Multiple Myeloma Treatment
去年
GPRC5D Emerges as Promising Target in Multiple Myeloma Clinical Trials
2年前
Bispecific Antibodies Show Promise in Multiple Myeloma Treatment Across Different Patient Populations
10天前
BMS GPRC5D CAR-T Arlo-cel Hits Primary Endpoint in Quadruple-Class Exposed Multiple Myeloma
去年
Talquetamab Shows Promise in Relapsed/Refractory Multiple Myeloma, Including Post-BCMA Failure
3年前
Novel BCMA-Targeted Therapies and Emerging Agents Transform Treatment Landscape for Relapsed/Refractory Multiple Myeloma
第 1 页,共 1516 页
上一页
下一页